Clinical Study
Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
Table 3
Subgroup analysis of the period of Goshajinkigan administration for peripheral neuropathy.
| ā | From the beginning of chemotherapy N = 15 | From the middle of chemotherapy N = 14 |
| Effect on peripheral neuropathy | Curative 1/15, 7.7% | Curative 0/14, 0% | Effective 2/15, 15.4% | Effective 4/14, 28.6% | Stabilizing 11/15, 69.2% | Stabilizing 9/14, 64.3% | Deleterious 1/15, 7.7% | Deleterious 1/14, 7.1% |
|
|